Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease

被引:51
作者
Chappell, S
Daly, L
Morgan, K
Baranes, TG
Roca, J
Rabinovich, R
Millar, A
Donnelly, SC
Keatings, V
MacNee, W
Stolk, J
Hiemstra, P
Miniati, M
Monti, S
O'Connor, CM
Kalsheker, N [1 ]
机构
[1] Univ Nottingham, Div Clin Chem, Inst Genet, Queens Med Ctr,Univ Nottingham Hosp, Nottingham NG7 2UH, England
[2] Univ Coll Dublin, Dept Publ Hlth Med & Epidemiol, Conway Inst, Dublin 2, Ireland
[3] Univ Coll Dublin, Dept Med & Therapeut, Conway Inst, Dublin 2, Ireland
[4] Hosp Clin Barcelona, Serv Pneumol, Hosp Clin, Barcelona, Spain
[5] Univ Bristol, Lung Res Grp, Dept Clin Sci N Bristol, Southmead Hosp, Bristol, Avon, England
[6] Letterkenny Gen Hosp, Letterkenny, Ireland
[7] Univ Edinburgh, ELEGI Colt Labs, Edinburgh, Midlothian, Scotland
[8] Leiden Univ, Dept Pulm C3P, Med Ctr, Leiden, Netherlands
[9] CNR, Inst Clin Physiol, I-56100 Pisa, Italy
关键词
alpha-1-antitrypsin; SERPINA1; alpha-1-antichymotrypsin; SERPINA3; COPD; SNP; polymorphism; haplotype;
D O I
10.1002/humu.20275
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Chronic obstructive pulmonary disease (COPD) is a major cause of mortality and morbidity worldwide. While cigarette smoking is a major cause of COPD, only 15% of smokers develop the disease, indicating major genetic influences. The most widely recognized candidate gene in COPD is SERPINA1, although it has been suggested that SERPINA3 may also play a role. To detect cryptic genetic variants that might contribute to disease, we identified 15 SNP haplotype tags from high-density SNP maps of the two genes and evaluated these SNPs in the largest case,control genetic study of COPD conducted so far. For SERPINA1, six newly identified haplotypes with a common backbone of five SNPs were found to increase the risk of disease by six- to 50-fold, the highest risk of COPD reported to date. In contrast, no haplotype associations for SERPINA3 were identified.
引用
收藏
页码:103 / 109
页数:7
相关论文
共 27 条
  • [1] Oncostatin M is a potent stimulator of α1-antitrypsin secretion in lung epithelial cells:: Modulation by transforming growth factor-β and interferon-γ
    Boutten, A
    Venembre, P
    Seta, N
    Hamelin, J
    Aubier, M
    Durand, G
    Dehoux, MS
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 18 (04) : 511 - 520
  • [2] INTERPRETATION OF BRONCHODILATOR RESPONSE IN PATIENTS WITH OBSTRUCTIVE AIRWAYS DISEASE
    BRAND, PLP
    QUANJER, PH
    POSTMA, DS
    KERSTJENS, HAM
    KOETER, GH
    DEKHUIJZEN, PNR
    SLUITER, HJ
    [J]. THORAX, 1992, 47 (06) : 429 - 436
  • [3] BRANTLY M, 1988, AM J MED, V84, P13
  • [4] Cavarra E, 1996, LAB INVEST, V75, P273
  • [5] Chappell Sally, 2004, Hum Mutat, V24, P535, DOI 10.1002/humu.9294
  • [6] CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659
  • [7] Genetics of chronic obstructive pulmonary disease
    DeMeo, DL
    Silverman, EK
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 24 (02) : 151 - 159
  • [8] NATURAL-HISTORY OF CHRONIC AIR-FLOW OBSTRUCTION
    FLETCHER, C
    PETO, R
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1977, 1 (6077): : 1645 - 1648
  • [9] Gulsvik A, 1999, Monaldi Arch Chest Dis, V54, P160
  • [10] Chronic obstructive pulmonary disease in α1-antitrypsin PI MZ heterozygotes:: a meta-analysis
    Hersh, CP
    Dahl, M
    Ly, NP
    Berkey, CS
    Nordestgaard, BG
    Silverman, EK
    [J]. THORAX, 2004, 59 (10) : 843 - 849